Keywords: alpha, therapeutic, track, oncolym, says, completed, dosimetry

Alpha Therapeutic On Track With Oncolym

Article | 06 November 1997

Print This

- Alpha Therapeutic says it has completed the dosimetry part of itsOncolym (I-131 LYM-1) trial. The radiolabeled monoclonal antibody is being ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in